Clene Inc. logo

Clene Inc.

NASDAQ:CLNN

Overview | Financials
Company Name Clene Inc.
Symbol CLNN
Currency USD
Price 6.74
Market Cap 43,608,272
Dividend Yield 0%
52-week-range 3.82 - 13.2
Industry Biotechnology
Sector Healthcare
CEO Mr. Robert Etherington MBA
Website https://clene.com

An error occurred while fetching data.

About Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof

Related Stocks

Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc.

FENC

5.47 USD

Savara Inc. logo

Savara Inc.

SVRA

4.2 USD

Compugen Ltd. logo

Compugen Ltd.

CGEN

1.97 USD

High Tide Inc. logo

High Tide Inc.

HITI

2.23 USD

NeuroPace, Inc. logo

NeuroPace, Inc.

NPCE

7.43 USD

Quipt Home Medical Corp. logo

Quipt Home Medical Corp.

QIPT

2.82 USD

Vor Biopharma Inc. logo

Vor Biopharma Inc.

VOR

1.05 USD

Harvard Bioscience, Inc. logo

Harvard Bioscience, Inc.

HBIO

2.88 USD

Financials

Numbers are in millions USD

Numbers are in millions USD